(1 - 14 from 18
)
Kinaxo Biotechnologies GmbH | Kinaxo Biotechnologies Awarded Grant to...
www.investegate.co.uk
Dr. Andreas Jenne, Kinaxo's CEO commented: "This funding will allow us to significantly expand the scope and utility of our chemical ...
KINAXO Extends Collaboration with Takeda
www.b3cnewswire.com
Dr. Andreas Jenne, KINAXO's CEO said: “We are very pleased to continue our collaboration with Takeda, a world leading healthcare company, and look forward to supporting Takeda's efforts in developing drugs. This collaboration once again ...
openPR.com - Press release - Kinaxo Biotechnologies GmbH ...
www.openpr.com
It underlines the benefits of our technology platform for developing the next generation of kinase inhibitors," said Dr. Andreas Jenne, CEO of KINAXO. "The KinaTorTM technology permits rational decisions based on ...
Evotec Acquires Kinaxo, Expanding Its Drug Discovery Platform With ...
www.globenewswire.com
Dr. Andreas Jenne, CEO of Kinaxo, adds: "We are excited to join forces with Evotec. Our technology portfolio perfectly fits into Evotec's integrated service offering. This will allow us to fully leverage our capabilities and grow our ...
sorted by relevance / date